Tender detail
Antineoplastic and immunomodulating medicines
Summary
Fakultná nemocnica s poliklinikou Žilina is procuring antineoplastic and immunomodulating medicines under a 12-month framework agreement with one supplier. The listed products include trastuzumab, pertuzumab, trastuzumab emtansine, a pertuzumab–trastuzumab combination and bevacizumab, in specified strengths and quantities; the estimated contract value is €947,648.50 excluding VAT.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.